Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis

Figure 8

Validated the expression levels of the 5 marker genes in two testing sets. (a–e) Differential expression analyses of F5, SORD, S100A12, RNF7, and MT4 between CAD samples and healthy controls in the GSE20681 dataset. (f–j) Differential expression analyses of F5, SORD, S100A12, RNF7, and MT4 between CAD samples and healthy controls in the GSE42148 dataset.